Atlas Trials

Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia

Clinical trial NCT02202226 · COMPLETED

Trial details

NCT number
NCT02202226
Sponsor
H. Lundbeck A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2013-01-01
Primary completion
2015-02-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.